This Article Full Text Full Text (PDF) All Versions of this Article: 40/4/1499    most recent STROKEAHA.108.532812v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Undas, A. Articles by Tracz, W. Search for Related Content PubMed PubMed Citation Articles by Undas, A. Articles by Tracz, W. Related Collections Fibrinolysis Fibrinogen/fibrin

(Stroke. 2009;40:1499.)
© 2009 American Heart Association, Inc.

Research Letters

Altered Fibrin Clot Structure/Function in Patients With Cryptogenic Ischemic Stroke

Anetta Undas, MD, PhD; Piotr Podolec, MD, PhD; Krystyna Zawilska, MD, PhD; Monika Pieculewicz, MD, PhD; Ireneusz Jedliski, MD; Ewa Stpie, PhD; Ewa Konarska-Kuszewska, MD, PhD; Przemysaw Wglarz, MD, PhD; Magorzata Duszyska, MD; Ewelina Hanschke, PhD; Tadeusz Przewocki, MD, PhD Wiesawa Tracz, MD, PhD

From Institute of Cardiology (A.U., P.P., M.P., E.S., T.P., W.T.), Jagiellonian University School of Medicine, Cracow, Poland; Department of Hematology (K.Z., E.H.), Karol Marcinkowski University of Medical Sciences, Poznan, Poland; Department of Cardiology, Joseph Strus Hospital (I.J., M.D.), Poznan, Poland; John Paul II Hospital (M.P., E.S.), Cracow, Poland; Department of Cardiology (E.K.-K., P.W.), Medical University of Silesia, Katowice, Poland.

Correspondence to Anetta Undas, MD, PhD, Institute of Cardiology, Jagiellonian University School of Medicine, 80 Pradnicka St, 31-202 Cracow, Poland. E-mail mmundas{at}cyf-kr.edu.pl

Background and Purpose— We tested the hypothesis that fibrin structure/function is unfavorably altered in patients with cryptogenic ischemic stroke.

Methods— Ex vivo plasma fibrin clot permeability, turbidimetry, and efficiency of fibrinolysis were determined in 89 patients with patent foramen ovale (PFO) and a history of first-ever stroke, 58 patients with first-ever stroke and no PFO, and 120 healthy controls.

Results— Stroke patients, evaluated 3 to 19 months after the event, and controls did not differ with regard to age, sex, smoking, and fibrinogen. Stroke patients with or without PFO had lower clot permeability (P<0.0001), faster fibrin polymerization (P<0.0001), prolonged clot lysis time (P<0.0001), higher maximum D-dimer levels released from clots (P<0.0001), and maximum rate of D-dimer release (P=0.02) than controls. Time from stroke occurrence showed no association with any clot variables. Scanning electron microscopy of fibrin clots showed increased fiber diameter and density in stroke patients. Clots from stroke patients with PFO were more permeable and showed shorter lysis time compared to those without PFO, and this was related to lower proportion of smokers in the former group.

Conclusions— Altered fibrin clot structure and resistance to fibrinolysis are associated with cryptogenic stroke.

Key Words: fibrin clot • fibrinolysis • stroke

This article has been cited by other articles:

				A. Undas, K. Zawilska, M. Ciesla-Dul, A. Lehmann-Kopydlowska, A. Skubiszak, K. Ciepluch, and W. Tracz Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives Blood, November 5, 2009; 114(19): 4272 - 4278. [Abstract] [Full Text] [PDF]